Protein-protein interactions: Inhibition of mammalian carbonic anhydrases I-XV by the murine inhibitor of carbonic anhydrase and other members of the transferrin family

Journal of Medicinal Chemistry

Volumn 55, Issue 11, 2012, Pages 5529-5535

  Durdagi, Serdar ^a   Vullo, Daniela ^b   Pan, Peiwen ^c   Kähkönen, Niklas ^c   Määttä, Juha A ^c   Hytönen, Vesa P ^c   Scozzafava, Andrea ^b   Parkkila, Seppo ^c   Supuran, Claudiu T ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF FLORENCE   (Italy)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOTRANSFERRIN; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE III; CARBONATE DEHYDRATASE INHIBITOR; ISOENZYME; LACTOFERRIN;

ARTICLE; BINDING AFFINITY; CATALYSIS; CONCENTRATION RESPONSE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DESIGN; DRUG EFFICACY; ENZYME INHIBITION; ENZYME STABILITY; ENZYMIC BIOSENSOR; HUMAN; INTERFEROMETRY; MOUSE; NONHUMAN; PH; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; THERMOSTABILITY; X RAY CRYSTALLOGRAPHY;

ANIMALS; APOPROTEINS; BIOLOGICAL ASSAY; BIOSENSING TECHNIQUES; CALORIMETRY, DIFFERENTIAL SCANNING; CARBONIC ANHYDRASES; HUMANS; ISOENZYMES; MICE; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN INTERACTION MAPPING; TRANSFERRINS;

EID: 84862280022     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm3004587     Document Type: Article

References (37)

1. Sheftel, A. D.; Mason, A. B.; Ponka, P. The long history of iron in the universe and in health and disease Biochim. Biophys. Acta 2012, 1820, 161-187
2. Lambert, L. A.; Perri, H.; Halbrooks, P. J.; Mason, A. B. Evolution of the transferrin family: conservation of residues associated with iron and anion binding Comp. Biochem. Physiol., Part B: Biochem. Mol. Biol. 2005, 142, 129-141
3. Gkouvatsos, K.; Papanikolaou, G.; Pantopoulos, K. Regulation of iron trasnport and the role of transferrin Biochim. Biophys. Acta 2012, 1820, 188-202
4. Papanikolaou, G.; Pantopoulos, K. Iron metabolism and toxicity Toxicol. Appl. Pharmacol. 2005, 202, 199-211
5. Baker, H. M.; Baker, E. N. Lactoferrin and iron: structural and dynamic aspects of binding and release BioMetals 2004, 17, 209-216
6. Wally, J.; Halbrooks, P. J.; Vonrhein, C.; Rould, M. A.; Everse, S. J.; Mason, A. B.; Buchanan, S. K. The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding J. Biol. Chem. 2006, 281, 24934-2444
7. Roush, E. D.; Fierke, C. A. Purification and characterization of a carbonic anhydrase II inhibitor from porcine plasma Biochemistry 1992, 31, 12536-12542
8. Wuebbens, M. W.; Roush, E. D.; Decastro, C. M.; Fierke, C. A. Cloning, sequencing, and recombinant expression of the porcine inhibitor of carbonic anhydrase: a novel member of the transferrin family Biochemistry 1997, 36, 4327-4336
9. Wang, F.; Lothrop, A. P.; James, N. G.; Griffiths, T. A.; Lambert, L. A.; Leverence, R.; Kaltashov, I. A.; Andrews, N. C.; MacGillivray, R. T.; Mason, A. B. A novel murine protein with no effect on iron homoeostasis is homologous with transferrin and is the putative inhibitor of carbonic anhydrase Biochem. J. 2007, 406, 85-95
10. Mason, A. B.; Judson, G. L.; Bravo, M. C.; Edelstein, A.; Byrne, S. L.; James, N. G.; Roush, E. D.; Fierke, C. A.; Bobst, C. E.; Kaltashov, I. A.; Daughtery, M. A. Evolution reversed: the ability to bind iron restored to the N-lobe of the murine inhibitor of carbonic anhydrase by strategic mutagenesis Biochemistry 2008, 47, 9847-9855
11. Eckenroth, B. E.; Mason, A. B.; McDevitt, M. E.; Lambert, L. A.; Everse, S. J. The structure and evolution of the murine inhibitor of carbonic anhydrase: a member of the transferrin superfamily Protein Sci. 2010, 19, 1616-1626
12. Supuran, C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators Nat. Rev. Drug Discovery 2008, 7, 168-181
13. Supuran, C. T. Carbonic anhydrase inhibitors Bioorg. Med. Chem. Lett. 2010, 20, 3467-3474
14. Pastorekova, S.; Parkkila, S.; Pastorek, J.; Supuran, C. T. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects J. Enzyme Inhib. Med. Chem. 2004, 19, 199-229
15. Supuran, C. T.; Mincione, F.; Scozzafava, A.; Briganti, F.; Mincione, G.; Ilies, M. A. Carbonic anhydrase inhibitors. Part 52. Metal complexes of heterocyclic sulfonamides: a new class of strong topical intraocular pressure-lowering agents with potential use as antiglaucoma drugs Eur. J. Med. Chem. 1998, 33, 247-254
16. Neri, D.; Supuran, C. T. Interfering with pH regulation in tumours as a therapeutic strategy Nat. Rev. Drug Discovery 2011, 10, 767-777
17. Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic anhydrase inhibitors Med. Res. Rev. 2003, 23, 146-189
18. Casini, A.; Scozzafava, A.; Mincione, F.; Menabuoni, L.; Ilies, M. A.; Supuran, C. T. Carbonic anhydrase inhibitors: water soluble 4- sulfamoylphenylthioureas as topical intraocular pressure lowering agents with long lasting effects J. Med. Chem. 2000, 43, 4884-4892
19. Alterio, V.; Hilvo, M.; Di Fiore, A.; Supuran, C. T.; Pan, P.; Parkkila, S.; Scaloni, A.; Pastorek, J.; Pastorekova, S.; Pedone, C.; Scozzafava, A.; Monti, S. M.; De Simone, G. Crystal structure of the extracellular catalytic domain of the tumor-associated human carbonic anhydrase IX Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 16233-16238
20. Lou, Y.; McDonald, P. C.; Oloumi, A.; Chia, S. K.; Ostlund, C.; Ahmadi, A.; Kyle, A.; Auf dem Keller, U.; Leung, S.; Huntsman, D. G.; Clarke, B.; Sutherland, B. W.; Waterhouse, D.; Bally, M. B.; Roskelley, C. D.; Overall, C. M.; Minchinton, A.; Pacchiano, F.; Carta, F.; Scozzafava, A.; Touisni, N.; Winum, J. Y.; Supuran, C. T.; Dedhar, S. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors Cancer Res. 2011, 71, 3364-3376
21. Ditte, P.; Dequiedt, F.; Svastova, E.; Hulikova, A.; Ohradanova-Repic, A.; Zatovicova, M.; Csaderova, L.; Kopacek, J.; Supuran, C. T.; Pastorekova, S.; Pastorek, J. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors Cancer Res. 2011, 71, 7558-7567
22. Battke, C.; Kremmer, E.; Mysliwietz, J.; Gondi, G.; Dumitru, C.; Brandau, S.; Lang, S.; Vullo, D.; Supuran, C.; Zeidler, R. Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII Cancer Immunol. Immunother. 2011, 60, 649-658
23. Mack, E. T.; Snyder, P. W.; Perez-Castillejos, R.; Whitesides, G. M. Using covalent dimers of human carbonic anhydrase II to model bivalency in immunoglobulins J. Am. Chem. Soc. 2011, 133, 11701-11715
24. Mack, E. T.; Snyder, P. W.; Perez-Castillejos, R.; Bilgicer, B.; Moustakas, D. T.; Butte, M. J.; Whitesides, G. M. Dependence of avidity on linker length for a bivalent ligand-bivalent receptor model system J. Am. Chem. Soc. 2012, 134, 333-345
25. Booth, V. H. The carbonic anhydrase inhibitor in serum J. Physiol. 1938, 91, 474-479
26. Ridderstråle, Y.; Fierke, C. A.; Roush, E. D.; Wistrand, P. J. Localization of a protein inhibitor of carbonic anhydrase in pig tissues Acta Physiol. Scand. 2002, 176, 27-31
27. Aspatwar, A.; Tolvanen, M. E.; Parkkila, S. Phylogeny and expression of carbonic anhydrase-related proteins BMC Mol. Biol. 2010, 11, 25
28. Khalifah, R. G. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C J. Biol. Chem. 1971, 246, 2561-2573
29. Whittington, D. A.; Waheed, A.; Ulmasov, B.; Shah, G. N.; Grubb, J. H.; Sly, W. S.; Christianson, D. W. Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 9545-9550
30. Whittington, D. A.; Grubb, J. H.; Waheed, A.; Shah, G. N.; Sly, W. S.; Christianson, D. W. Expression, assay, and structure of the extracellular domain of murine carbonic anhydrase XIV: implications for selective inhibition of membrane-associated isozymes J. Biol. Chem. 2004, 279, 7223-7228
31. Di Fiore, A.; Monti, S. M.; Hilvo, M.; Parkkila, S.; Romano, V.; Scaloni, A.; Pedone, C.; Scozzafava, A.; Supuran, C. T.; De Simone, G. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide Proteins 2009, 74, 164-175
32. Di Fiore, A.; Truppo, E.; Supuran, C. T.; Alterio, V.; Dathan, N.; Bootorabi, F.; Parkkila, S.; Monti, S. M.; De Simone, G. Crystal structure of the C183S/C217S mutant of human CA VII in complex with acetazolamide Bioorg. Med. Chem. Lett. 2010, 20, 5023-5026
33. Hilvo, M.; Baranauskiene, L.; Salzano, A. M.; Scaloni, A.; Matulis, D.; Innocenti, A.; Scozzafava, A.; Monti, S. M.; Di Fiore, A.; De Simone, G.; Lindfors, M.; Janis, J.; Valjakka, J.; Pastorekova, S.; Pastorek, J.; Kulomaa, M. S.; Nordlund, H. R.; Supuran, C. T.; Parkkila, S. Biochemical characterization of CA IX: one of the most active carbonic anhydrase isozymes J. Biol. Chem. 2008, 283, 27799-27809
34. Matulis, D.; Kranz, J. K.; Salemme, F. R.; Todd, M. J. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor Biochemistry 2005, 44, 5258-5266
35. Pommier, Y.; Marchand, C. Interfacial inhibitors: targeting macromolecular complexes Nat. Rev. Drug Discovery 2012, 11, 25-36
36. Reichert, J. M. Antibody-based therapeutics to watch in 2011 mAbs 2011, 3, 76-99
37. Perez-Sayans, M.; Garcia-Garcia, A.; Scozzafava, A.; Supuran, C. T. Inhibition of V-ATPases and carbonic anhydrases as interference strategy with tumor acidification processes Curr. Pharm. Des. 2012, 18, 1407-1413